HORIZON THERAPEUTICS LTD
Business Summary
Horizon Therapeutics Ltd is a United States-based biopharmaceutical company. The Company is engaged in the development and commercialization of medicines for the treatment of patients with serious or life-threatening diseases. The Company is focused on the discovery, development and commercialization of medicines that address needs for people affected by rare, autoimmune, and severe inflammatory diseases. The Company's drug portfolio includes ACTIMMUNE, BUPHENYL (sodium phenylbutyrate), PROCYSBI (cysteamine bitartrate), Prescription RAVICTI (glyceryl phenylbutyrate), and others.
Country of Incorporation
Ireland
Incorporation Date
2011-12-20
Business Sector
Pharmaceuticals & Medical Research
Company Address
Connaught House, 1St Floor, 1 Burlington Road
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.NEWS ON THIS COMPANY
TOP PICKS
MOST READ
MOST WATCHED
MOST POPULAR
1.
2.
3.
4.
5.
